<DOC>
	<DOCNO>NCT00597532</DOCNO>
	<brief_summary>To Test Effect Soy Supplementation Cellular Markers Normal Cancerous Breast Tissue use Randomized Placebo Controlled Study . Objectives : - To determine ( immunohistochemistry ) whether specific cellular marker gene product associate breast carcinoma alter soy therapy . - To identify gene alter soy therapy normal neoplastic breast tissue unbiased gene expression analysis use microarrays . - To compare specific cellular marker pathway ( immunohistochemistry ) , gene expression use microarrays normal cancerous breast tissue .</brief_summary>
	<brief_title>Effect Soy Supplementation Cellular Markers Normal Cancerous Breast Tissue : A Randomized Placebo Controlled Study</brief_title>
	<detailed_description>Patient Population : Pre post menopausal woman breast cancer diagnose core needle biopsy schedule undergo breast cancer resection invasive carcinoma . Objectives : - To determine ( immunohistochemistry ) whether specific cellular marker gene product associate breast carcinoma alter soy therapy . - To identify gene alter soy therapy normal neoplastic breast tissue unbiased gene expression analysis use microarrays . - To compare specific cellular marker pathway ( immunohistochemistry ) , gene expression use microarrays normal cancerous breast tissue . Study Design Intervention Plan : - Eligible patient consent time visit MSKCC breast surgeon randomize receive soy ( soy protein supplementation 50 grams/day ) , placebo ( milk protein supplementation 50 grams/day ) period surgery . - The diagnostic biopsy ( already available time appointment MSKCC surgeon ) analyze immunohistochemistry proliferation ( Ki67 ) apoptosis ( TUNEL ) . Additional immunohistochemistry include HER2 , TP53 , cyclin D1 , p27 , BCL2 , ER PR . - Excision breast carcinoma ( lumpectomy mastectomy ) proceed standard fashion . - The post-therapy excision specimen process standard fashion . Pathologic feature , margin status , tumor size assess light microscopic examination histological section . In addition routine processing , immunohistochemistry assay proliferation ( Ki67 ) , apoptosis ( TUNEL ) , HER2 , TP53 , cyclin D1 , p27 , BCL2 , ER , PR perform . For correlative biological study pathologist select approximately .5 cubic mm representative section neoplastic tissue normal adjacent breast tissue , snap frozen gene expression analysis use microarrays .</detailed_description>
	<criteria>Informed consent obtain Breast mass &gt; .5 cm ( determined mammogram , ultrasound , MRI , palpable criterion ) Core biopsy diagnosis invasive carcinoma breast History active malignancy within previous two year ( except nonmelanoma skin cancer history breast cancer ) . Regular soy consumption ( consumption 3 serve soy soy products/supplements per week ) Allergy soy milk protein</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Soy</keyword>
	<keyword>Milk</keyword>
	<keyword>Supplementation</keyword>
	<keyword>02-062</keyword>
</DOC>